CASI Pharmaceuticals
CASI
CASI
44 hedge funds and large institutions have $20.7M invested in CASI Pharmaceuticals in 2018 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 13 increasing their positions, 10 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
0.16% more ownership
Funds ownership: 0.55% → 0.71% (+0.16%)
Holders
44
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$1.62M | |
| 2 | +$1.46M | |
| 3 | +$751K | |
| 4 |
Goldman Sachs
New York
|
+$664K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$485K |
Top Sellers
| 1 | -$453K | |
| 2 | -$167K | |
| 3 | -$97K | |
| 4 |
Barclays
London,
United Kingdom
|
-$85.7K |
| 5 |
AGM
Alpine Global Management
New York
|
-$66K |